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Background: Caesarean section(C/S) has been found to increase rates of maternal infectious morbidities five times
more than vaginal delivery. The provision of intravenous prophylactic antibiotics 30 to 60 minutes prior to C/S has
been found to substantially reduce post-caesarean infection. At Bugando Medical Centre, there is no consistent
protocol for the administration of antibiotic prophylaxis to patients who are undergoing emergency C/S. Providing
repeated dosages of antibiotic prophylaxis after C/S is the common practice. This study aimed to determine the
comparative efficacy of a single dose of gentamicin in combination with metronidazole versus multiple doses for
prevention of post-caesarean infection.
Methods: From October 2011 to May 2012, a randomized, equivalence, non-blinding clinical trial was conducted at
Bugando Medical Centre in Mwanza, Tanzania. A total of 500 eligible participants were enrolled in the study and
were randomly allocated into two study arms -- “A” and “B”. Participants in “A” received a single dose of gentamicin
in combination with metronidazole 30 to 60 minutes prior to the operation, and participants in “B” received the
same drugs prior to the operation but continued with for 24 hours. Both groups had 30 days of follow-up and
were assessed for signs and symptoms of surgical-site infection as the primary outcome. The equivalence margin
was set at 5%. The two-tailed equivalence was analyzed based on intention- to-treat analysis.
Results: The randomization was proper, as the distribution of various demographic and other baseline
characteristics had a p-value of > 0.05. All 500 participants were included in our analysis; of these, no participants
were lost to follow-up. Surgical-site infection occurred in 12 out of the 250 (4.8%) receiving single dose compared
to 16 out of the 250 (6.4%) receiving multiple doses. There is an absolute proportion difference of 1.6% (95%
Confidence interval: -2.4 – 5.6%) which lies outside the pre-specified 5% equivalence margin.
Conclusion: We recommend the administration of pre-operative single dose antibiotic prophylaxis for emergency
caesarean as this intervention proved to be not equivalent to multiple doses antibiotic prophylaxis in reducing
surgical site infection. Single dose therapy also reduces staff workload along with medication costs.
Trial registration: Current Controlled Trials ISRCTN44462542.
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Postpartum infection remains to be among the top five
causes of pregnancy-related maternal mortality and mor-
bidity worldwide [1-3]. Women who undergo caesarean
section have a 5 to 20 fold greater risk of postpartum in-
fection than women having a vaginal delivery [4-7]. The
incidence of post-cesarean infection varies widely world-
wide – ranging from 2.5% to 20.5% [8-12].
Selection of antibiotics for prophylaxis follows the
principle that the selected antibiotic regimen should have
activity against microbial agents commonly involved in
surgical-site contamination and actual infection. A com-
bination of clindamycin and aminoglycosides has been
recommended as the treatment of choice in post-caesarean
infection, since it covers most of the pathogenic bacteria
commonly involved in post-caesarean infection. Alterna-
tively, a combination of metronidazole with aminogly-
cosides has been found to be effective [13-15]. Apart from
being a drug of choice in treating gram-negative bacteria,
methicillin sensitive Staphylococcus aureus responds to
gentamicin [15,16].
A number of well-designed studies have documented
the efficacy of prophylactic antibiotics in reducing the
rates of post-partum infection among patients who have
undergone caesarian section [8-12]. Administration of
antibiotic prophylaxis within an hour prior to skin incision
is more effective in reducing post-caesarean infectious
morbidity when compared to administration of the same
drugs after cord clamping and has no effect on neonatal
infection [17-21]. In a systematic review, Owens et al.
reported that provision of antibiotic prophylaxis for cae-
sarean section before skin incision compared with after
umbilical cord clamping is associated with a 40% decrease
in postpartum endometritis and a 30% decrease in wound
infection [22]. Provision of a single dose of antibiotics pre-
operatively has been found to be as effective as multiple
doses in prevention of postpartum infection [23-25].
At Bugando Medical Centre (BMC), the rate of caesar-
ian is estimated to be 20% [26]. All patients who deliver
by caesarian section receive antibiotic prophylaxis. How-
ever, there is no consistent protocol for administration of
antibiotic prophylaxis for patients designated for caesar-
ean section. The common practice is to provide repeated
doses of prophylactic antibiotics for at least 24 hours after
caesarian section and often on individual clinicians’ prac-
tice and preference. Gentamicin and metronidazole are
among the antibiotics that are used as prophylaxis for in-
fection during caesarean delivery.
This study aimed to determine the equivalence of intra-
venous single dose of gentamicin (3mg/kg) plus metro-
nidazole (500mg) given 30 to 60 minutes before incision
and multiple doses of gentamicin (3mg/kg) plus metro-
nidazole (500mg) given 30 to 60 minutes before incision




This was an interventional, open label, two-armed, ran-
domized, single-centre, equivalence trial conducted at
BMC -- a zonal consultant and teaching hospital situated
in Mwanza City, Tanzania. In this hospital, 7149 pregnant
women are admitted yearly. There are 6868 deliveries per
annum, and 1398 (20.3%) pregnant women deliver by cae-
sarean section as per 2010 statistics [26].
The target population was all pregnant women who
were admitted at BMC labor ward that needed or had indi-
cation for emergency caesarean section, between the dates
of October 2011 and May 2012. All pregnant women who
were required to undergo emergency caesarean section
(under spinal anaesthesia) and had also consented for the
study were eligible for inclusion, but the study excluded all
pregnant women with fever (temperature of 38°C and
above,) prolonged obstructed labor, and prolonged and
premature rupture of membranes (rupture of membrane
more than twelve hours). Pregnant women presenting with
features of chorioamnionitis (i.e. foul smelling lochia, uter-
ine tenderness associated with fever) allergies to the antibi-
otics used in the study, or those who had used antibiotics
in the 24 hours preceding the operation or unconscious
patients who could not provide consent were excluded
from the study.
Sample size estimation
Sample size was estimated according to our previously
reported protocol [27]. Briefly, we used the formula for
proportion difference for equivalence trial with hypothe-
sized difference of 5% (i.e. within this difference, the two
regimes are assumed to be clinically equivalent, alpha =
0.05 and beta = 0.20) [28]. By considering 10% of parti-
cipants non-response or lost to follow up, the required
minimum sample size was 490 (i.e. 245 participants per
group). However we managed to recruit 500 participants --
250 on each study arm.
Randomization
Simple randomization was used to allocate study partici-
pants. A total of 500 opaque envelopes of the same size
were prepared for this study; 250 envelopes contained
papers marked “study arm A,” and the remaining enve-
lopes contained papers marked “study arm B.” Before
envelopes were picked, all envelopes were thoroughly
mixed together in a box to allow equal chance of being
selected. Each study participant selected one sealed enve-
lope and then gave it to the research assistant to open.
Antibiotic prophylaxis was prescribed according to the
study arm.
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Intervention started after allocating eligible participants
into two study arms: A and B. Study arm A included those
who received a single intravenous single dose of gentami-
cin (3mg/Kg) plus metronidazole (500mg) 30 to 60 mi-
nutes before operation, and study arm B included those
who received multiple doses of gentamicin (3mg/Kg) plus
metronidazole (500mg) 30 to 60 minutes before operation
and metronidazole (500mg every) 8 hours for 24 hours
postoperatively.
Specific objectives and hypothesis
The specific objective was to determine the equivalence
between intravenous single dose gentamicin (3mg/Kg)
plus metronidazole (500mg) 30 to 60 minutes before op-
eration and multiple doses of gentamicin (3mg/Kg) plus
metronidazole (500mg) 30 to 60 minutes before operation
and metronidazole (500mg) every 8 hours for 24 hours
postoperatively.
Null hypothesis
The treatment difference on the proportion of post-
caesarian section infection in the two arms should be
more than ± 5%.
Alternative hypothesis
The treatment difference on the proportion of post-
caesarian section infection in the two arms should be less
than or equal to ± 5%.
Outcomes
Primary outcome measure
Post-caesarean, surgical-site infection was our primary
outcome. The assessment for any evidence of surgical-site
infection was done 72 hours after caesarian section, as
well as on follow-up days (day 7 and day 30 post-cae-
sarean section). Two clinicians in the ward who were not
involved in the study performed diagnosis of surgical-site
infection. The presence of fever (febrile morbidity) signs
and symptoms of abdominal wound infection or endomet-
ritis indicated surgical-site infection.
Febrile morbidity was defined by temperature above
38°C at least 4 hours apart on two or more occasions, ex-
cluding the first 24 hours after delivery [29]. Abdominal
wound infection was defined by partial or total dehis-
cence, presence of purulent or serous discharge from the
wound with indurations, warmth and tenderness. Endo-
metritis was defined by the presence of fever (38°C or
above) in association with one or more of the following:
uterine tenderness or foul smelling lochia [29]. A diagno-
sis of surgical site infection was reached by using criteria
put forth by Centers for Disease Control and Prevention
(CDC) [30-32].In both groups, the bladder catheter was removed after
24 hours. The occlusive dressing which was applied in
theatre was removed after 48 hours and the wound was
left open. Assessment of for signs of infection was done
on days 3, 7 and 30 post-operatively. We selected these
three days because; on day 3 the patient is normally
discharged from the hospital if she is doing well, day 7 is
when stitches on the wound are removed and day 30 is for
final follow up according to CDC definition of surgical site
infection. However, before discharging our patients, we
educated them on the signs of infection so that they could
come any time they feel ill or notice signs suggestive of in-
fection. Assessment was done by measuring body tem-
perature at axilla and performs physical examination. The
diagnosis of surgical site infection was made if the infec-
tion occurs within 30 days of follow up. Patients with
surgical site infection were managed by using hospital
treatment guideline.
Secondary outcome measure
There were no secondary outcome measures (such as side
effects of drugs) simply because the study did not involve
a new drug or a new regimen. It was just a comparison of
efficacy of a single dose over repeated doses of the same
drug combinations.
Statistical analysis
All data were extracted from patients’ files and used to fill
in a case record form designed for this study. The
recorded data included socio-demographic characteristics,
obstetric history and labor history if any (stage of labor,
state of amniotic membrane-whether intact or ruptured)
and information on the HIV status of all women was
extracted from either the antenatal cards or the patients’
files. Regarding testing for HIV, the current policy is that
every woman admitted at Bugando Medical Centre is re-
quested to test for HIV. A trained counselor was available
in the labour room to counsel all women coming for de-
livery. Testing was done according to Tanzania Ministry
of Health recommendation. Other patient information
was added during follow-up.
Participants who could not attend their follow up days
were traced and assessed. We made contact through their
own mobile phone numbers or their husbands’, or nearby
relatives or by communicating with a ten cell leader since
we had their physical addresses. Study participants were
reminded to attend their follow-up days by phone call a
day before.
Data were double entered into computer using EpiData
version 3.1 (CDC, Atlanta, USA) according to codes given.
Data were checked for discrepancies and then exported to
STATA version 11 (college Station, Texas, USA) for ana-
lysis. Descriptive statistics were used to summarize partici-
pants’ characteristics. Cumulative incidence was calculated
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over total number of participants in each study group.
Time to develop post-caesarean infection was noted and
used to calculate the incidence rate (IR) of post-caesarean
infection. IR was calculated by using a number of study
subjects with infection divided by total person-days of fol-
low up in each study group. Intention-to-treat analysis
was used to determine the equivalence between a single
dose and multiple dose regimens; we set the equivalence
margin at 5%. The difference in proportion with its corre-
sponding 95% confidence interval was computed. The
equivalence was considered statistically significant at two-
tailed if the 95% confidence interval of the proportion dif-
ference lies within the pre-specified equivalence margin
of ± 5%.
Results
Characteristics of the study population
This study was conducted between October 2011 and
May 2012. A total of 749 pregnant women were assessed
for eligibility. Of these, 249 participants were excluded
from the study (220 participants did not meet the inclu-
sion criteria, 21 participants declined to participate in the


































Figure 1 Participant’s flow chart.500 pregnant women were randomly allocated into two
arms; 250 received a single dose regime and 250 received
multiple dose regimes (Figure 1). No participants in either
arm were lost to follow-up. There was an even distribu-
tion of the participants with respect to demographic and
other baseline characteristics in both arms (p-value >0.05)
as shown in Table 1.
Equivalence of single dose and multiple dose regimens
Post caesarian section surgical-site infection occurred in
12/250 (4.8%) among those that received single dose com-
pared to 16/250 (6.4%) of those that received multiple
doses. An absolute proportion difference of 1.6%, with 95%
confidence interval (CI) -2.4 – 5.6% was observed. Since
95% CI was not within the pre-specified equivalence mar-
gin of ± 5%, we failed to accept the equivalence hypothesis.
Participants who used the single dose regime had lower
cumulative incidences than those who used multiple
doses, (4.8% [95% CI 2.2 – 7.4] versus 6.4% [95% CI 3.4 –
9.4]) as shown in Figure 2.
Incidence of post-caesarean infection
The incidence rates of post-caesarean infections were 1.7
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Table 1 Background parameters in the two groups of
women subjected to emergency caesarean section using








20 years and below 38 (15.2%) 42 (16.8%) 0.612
21-30 years 146 (58.4%) 135 (54.0%)
Above 30 years 66 (26.4%) 73 (29.2%)
Gravidity
Primegravida 77 (30.8%) 83 (33.2%) 0.565
Multigravida 173 (69.2%) 167 (66.8%)
Body mass index (kg/m2 )
Normal weight 55 (22%) 67 (26.8%) 0.123
Overweight 112 (44.8%) 120 (48.0%)
Obese 83 (33.2%) 63 (25.2%)
Presence of caesarean section
scar
NO 152 (60.8%) 163 (65.2%) 0.308
YES 98 (39.2%) 87 (34.8%)
Amniotic membrane during
operation
Intact 121 (48.4%) 92 (36.8%) 0.009
Ruptured 129 (51.6%) 158 (63.2%)
Duration of operation
(minutes)
≤60 minutes 151 (60.4%) 140 (56.0%) 0.319
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Figure 2 Kaplan-Meier cumulative incidence of Post
caesarean infection.
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(IRR) of 0.74 [95% CI 0.32 – 1.65 p-value = 0.2146].
Discussion
This study demonstrated that the administration of intra-
venous single dose of gentamicin (3mg/kg) in combin-
ation with 500 mg of metronidazole and multiple doses of
the same regimen given within 24 hours before emergency
caesarean section for prevention of infection are not sta-
tistically equivalent. The administration of pre-operative
single dose antibiotic prophylaxis has shown to have lower
cumulative incidence of surgical-site infection compared
to multiple doses. Previous studies have reported that
there is no added benefit of using multiples doses over
single dose of antibiotics for prophylaxis of SSI [23,33].
For this reason the administration of pre-operative single
dose antibiotic prophylaxis for emergency caesarean is
recommendable. This is also supported by the 1998
Swedish and Norwegian consensus on the use of antibiotic
prophylaxis in surgery, which states that the choice of an-
tibiotics should be generally conservative. Antibiotics used
for therapy should be avoided in prophylactic regimens. Inmost cases, surgical antibiotic prophylaxis should be given
as a single dose, and in no case should the prophylaxis
time exceed 24 hours [34].
Costs of medications are an important parameter espe-
cially is resource-limited settings such as ours where most
of the patients do not have health insurance. Multiple
doses regime is associated with higher medication cost
than single dose regime. Furthermore, previous studies
have shown the low prevalence of low-level resistance to
gentamicin in our setting [35,36]. Therefore, when consid-
ering medication cost and drug-susceptibility pattern of
the common bacteria causing surgical-site infection in our
setting, single dose regime for prophylaxis is the rational
choice.
In addition, the use of single dose regime reduces work-
load to the nurses, especially at night when few nurses are
on duty in the ward. The severe shortage of health care
workers is a well-known problem in many resource-
limited settings [37]. For instance, the total of staffing in
the health sector of Tanzania stands at 35% of the actual
need [38]. This causes the few available nurses to be
overwhelmed by their duties and sometimes fail to attend
to the patients in a timely manner. Consequently, the use
of single dose regimen is particularly pertinent for settings
with scarcity of health care workers.Conclusion
The administration of intravenous single dose of gentami-
cin (3mg/kg) in combination with 500 mg of metronida-
zole and multiple doses of the same regimen given within
24 hours before emergency caesarean section for preven-
tion of infection are not statistically equivalent. Therefore,
we recommend the administration of pre-operative single
dose antibiotic prophylaxis for emergency caesarean, as
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of surgical-site infection with reduced staff workload and
minimized medication cost as compared to multiple
doses.
Ethical approval
This trial did not involve new drugs but only determined
the efficacy of a single dose regime versus multiple dose
regimes; however GCP and Declaration of Helsinki were
observed. Clearance for conducting this study was sought
from the Bugando Research Ethics Committee on 22nd
August 2011 ref: BREC/001/39/2011.
An informed consent was requested from participants
after explaining the study aims. For literate women, the
consent information was provided before providing a copy
of the consent form that each participant was required
to sign.
For non-literate women, the consent information was
read in full, and participants were required to thumb print
on the consent form to signify their acceptance to partici-
pate in the study. A nurse or doctor who was not part of
the study was around to witness the verification counsel-
ing process for illiterate women.
Participation was voluntary, and those who declined to
participate were still entitled to the standard care provided
to all women in the labor ward.
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